Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.5.664

Association of β3-Adrenergic Receptor Polymorphisms and High-Density Lipoprotein Cholesterol  

Yu, Byeng-Chul (Department of Preventive Medicine and Institute of Natural Products for Health Promotion, Kosin University)
Jeon, Man-Joong (Department of Preventive Medicine and Institute of Natural Products for Health Promotion, Kosin University)
Lee, Yong-Hwan (Department of Preventive Medicine and Institute of Natural Products for Health Promotion, Kosin University)
Publication Information
Journal of Life Science / v.19, no.5, 2009 , pp. 664-670 More about this Journal
Abstract
The ${\beta}$3-adrenergic receptor (ADRB3) is expressed mainly in visceral adipose tissue and is thought to contribute to lipolysis and the delivery of free fatty acids to the portal vein. This study was aimed at evaluating the association between high-density lipoprotein cholesterol (HDL-C) and ADRB3 genetic polymophisms. A total of 991 healthy examinees who were examined in a university hospital, located in Busan City, between May and December 2006 were enrolled in this study. Height, weight, body mass index, waist circumference, and systolic and diastolic blood pressures of the subjects were examined. Intravenous concentrations of fasting blood glucose, total cholesterol, HDL-C, low-density lipoprotein cholesterol, and triglyceride were also measured. After extracting DNA from the subjects, mutations of the +188T>C (Trp64Arg) of exon 1 and +3893T>C of intron 2 on the ADRB3 gene were genotyped using the single base extension method. We have identified a novel mutation of ADRB3 that is located in intron 2. The frequency of its minor allele was 0.164. Both the +188T>C mutation of exon 1 and +3893T>C mutation of intron 2 were significantly associated with HDL-C. The mean concentration of serum HDL-C was significantly lower in the presence of their minor allele 'C'. These results suggest that both mutations of +188T>C of exon 1 and +3895T>C of intron 2 have significant associations with HDL-C in the Korean population.
Keywords
ADRB3 gene; high-density lipoprotein cholesterol; polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Walston, J., K. Silver, C. Bogardus, W. C. Knowler, F. S. Celi, S. Austin, B. Manning, A. D. Strosberg, M. P. Stern, N. Raben, J. D. Sorkin, J. Roth, and A. R. Shuldiner. 1995. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic-receptor gene. N. Engl. J. Med. 333, 343-347   DOI   ScienceOn
2 Widen, E., M. Lehto, T. Kanninen, J. Walston, A. R. Shuldiner, and L. C. Groop. 1995. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333, 348-351   DOI   ScienceOn
3 Yoshida, T., N. Sakane, T. Umekawa, M. Sakai, T. Takahashi, and M. Kondo. 1995. Mutation of $\beta$3 adrenergic receptor gene and response to treatment of obesity. Lancet 1433-1434
4 Yuan, X., K. Yamada, K. Koyama, F. Ichikawa, S. Ishiyama, A. Koyanagi, W. Koyama, and K. Nonaka. 1997. Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res. Clin. Pract. 37, 1-7   DOI   ScienceOn
5 Perfetti, R., H. Hui, K. Chamie, S. Binder, M Seibert, J. McLenithan, K. Silver, and J. D. Walston. 2001. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J. Mol. Endocrinol. 27, 133-144   DOI   ScienceOn
6 Rissanen, J., J. Kuopusjarvi, J. Pihlajamaki, R. Sipilainen, S. Heikkinen, M. Vanhala, P. Kekalainen, J. Kuusisto, and M. Laakso. 1997. The Trp64Arg polymorphism of the beta3-Adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 20, 1319-1323   DOI   ScienceOn
7 Thomas, G. N., B. Tomlinson, J. C. N. Chan, R. P. Young, and J. A. J. H. Critchley. 2000. The Trp64Arg polymorphism of the β3-adrnergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int. J. Obes. 24, 545-551   DOI   ScienceOn
8 Rho, Y. H., S. J. Choi, Y. H. Lee, J. D. Ji, and G. G. Song. 2007. The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor. Rheumatol. Int. 27, 835-839   DOI   ScienceOn
9 Shiwaku, K., A. Nogi, E. Anuurad, K. Kitajima, B. Enkhmaa, K. Shimono, and Y. Yamane. 2003. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int. J. Obes. Relat. Metab. Disord. 27, 1028-1036   DOI   ScienceOn
10 Tamaki, S., Y. Nakamura, Y. Tabara, T. Okamura, Y. Kita, T. Kadowaki, Y. Tsujita, M. Horie, T. Miki, and H. Ueshima. 2006. Relationship between metabolic syndrome and Trp64Arg polymorphism of the $\beta$3-adrenergic receptor gene ina general sample: the Shigaraki Study. Hypertens Res. 29, 891-896   DOI   ScienceOn
11 Urhammer, S. A., J. O. Clausen, T. Hansen, and O. Pedersen. 1996. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes 45, 1115-1120   DOI   ScienceOn
12 Kissebah, A. H., G. E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R. G. James, J. A. Marks, G. R. Krakower, H. J. Jacob, J. Weber, L. Martin, J. Blangero, and A. G. Comuzzie. 2000. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. 97, 14478-14483   DOI   ScienceOn
13 Lehman, D. M., J. Hamlington, K. J. Hunt, R. J. Leach, R. Arya, H. Abboud, R. Duggirala, J. Blangero, H. H. Goring, and M. P. Stern. 2006. A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family. Diabetes Metab. Res. Rev. 22, 331-336   DOI   ScienceOn
14 Matsushita, Y., T. Yokoyama, N. Yoshiike, Y. Matsumura, C. Date, K. Kawahara, and H. Tanaka. 2003. The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with body weight or body mass index in Japanese: A longitudinal analysis. J. Clin. Endocrinol. Metab. 88, 5914-5920   DOI   ScienceOn
15 Li, L. S., F. Lonnqvist, H. Luthman, and P. Arner. 1996. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39, 857-860
16 Lowell, B. B., V. S. Susulic, A. Hamann, J. A. Lawitts, J. Himms-Hagen, B. B. Boyer, L. P. Kozak, and J. S. Flier. 1993. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742   DOI   ScienceOn
17 Masuo, K., T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck. 2005. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 28, 3429-3434
18 Miyaki, K., S. Sutani, H. Kikuchi, I. Takei, M. Murata, K. Watanabe, and K. Omae. 2005. Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the $\beta$3-adrenergic receptor gene in healthy Japanese men. J. Epidemiol. 15, 203-210   DOI   ScienceOn
19 Dunajska, K., F. Lwow, A. Milewicz, D. Jedrzejuk, L. Laczmanski, K. Belowska-Bien, J. Urban, and A. Szuba. 2008. beta(3)-adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women. Gynecol. Endocrinol. 24, 133-138   DOI   ScienceOn
20 Emorine, L. J., S. Marullo, M. M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and A. D. Strosberg. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science 245, 1118-1121   DOI
21 Hedrick, P. W. 1987. Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341
22 Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
23 Garcia-Rubi, E. and J. Calles-Escandon. 1999. Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch. Med. Res. 30, 459-464   DOI   ScienceOn
24 Hamann, A., H. Benecke, Y. Le Marchand-Brustel, V. S. Susulic, B. B. Lowell, and J. S. Flier. 1995. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44, 1266-12738   DOI   ScienceOn
25 Hegele, R. A., S. Harris, A. J. G. Hanley, H. Azouz, P. W. Connelly, and B. Zimman. Absence of association between genetic variation of the $\beta$3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 21, 851-854   DOI   ScienceOn
26 Kadowaki, H., K. Yasuda, K. Iwamoto, S. Otabe, K. Shimokawa, K. Silver, J. Walston, H. Yoshinaga, K. Kosaka, N. Yamada, Y. Saito, R. Hagura, Y. Akanuma, A. Shuldiner, Y. Yazaki, and T. Kadowaki. 1995. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215, 555-560   DOI   ScienceOn
27 Chamberlain, P. D., K. H. Jennings, F. Paul, J. Cordell, A. Berry, S. D. Holmes, J. Park, J. Chambers, M. V. Sennitt, M. J. Stock, M. A. Cawthorne, P. W. Young, and G. J. Murphy. 1999. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int. J. Obes. Relat. Metab. Disord. 23, 1057-1065   DOI   ScienceOn
28 Clement, K., C. Vaisse, B. S. Manning, A. Basdevant, B. Guy-Grand, J. Ruiz, K. D. Silver, A. R. Shuldiner, P. Froguel, and A. D. Strosberg. 1995. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333, 352-354   DOI   ScienceOn
29 Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, and J. S. Mattick. 1991. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19, 4008   DOI   ScienceOn